stants: a minority (2%-5%) of high-affinity (0.1 nM) receptors and a majority (95%-98%) of low-affinity (10 nM) receptors. The high-affinity receptors are lost upon membrane solubilization or following protein kinase C-mediated phosphorylation of Thr-654 in the juxtamembrane domain of EGFR (reviewed in Ullrich and Schlessinger, 1990 ). In addition, a soluble form of the extracellular domain exhibits low-affinity binding toward EGF, while a truncated form lacking most of the second cysteine-rich domain (IV) binds EGF or TGF␣ with at least ten-fold higher affinity than the full-length ECD (Garrett et al., 2002) . It was also reported that the binding affinity of EGF toward EGFR is modulated by coexpression of ErbB2, or ErbB3 in the same cells, two members of the receptor family that do not bind directly to EGF. Similar modulation of the binding affinity of Heregulin toward ErbB3 or ErbB4 was also detected in cells coexpressing EGFR or ErbB2. The crystal structures presented in the two reports provide new insights into these puzzling observations. The dimerization loop-mediated mechanism of receptor dimerization may function as a key regulatory step for control of the PTK activity of EGFR and other members of the family. Accordingly, EGF-induced receptormediated dimerization will facilitate intermolecular autophosphorylation that in turn will maintain the PTK domain in an active state. Receptor-mediated dimerization may also provide a potential explanation for the strong stimulation of the PTK activity caused by overexpression of erbB2. As the dimerization loop of ErbB2 is maintained in the active configuration, overexpression of ErbB2 will facilitate spontaneous dimerization of the receptor, resulting in trans autophosphorylation and further stimulation of ErbB2 PTK activity.
Future structural and biochemical experiments will reveal the potential role of the second cysteine-rich domain (domain IV) in receptor autoinhibition and control of receptor oligomerization and the important unanswered question of how ligand-induced receptor dimerization activates the cytoplasmic protein tyrosine kinase activity. 
